4basebio PLC (ETR:88Q)
Germany · Delayed Price · Currency is EUR 9.00
+0.55 (6.51%)
Oct 10, 2025, 7:49 AM CET
4basebio Market Cap
4basebio has a market cap or net worth of €140.42 million as of October 17, 2025. Its market cap has decreased by -33.82% in one year.
Market Cap
140.42M
Enterprise Value
128.16M
Revenue
2.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
€9.00
Market Cap Chart
Since February 17, 2021, 4basebio's market cap has increased from 47.83M to 140.42M, an increase of 193.57%. That is a compound annual growth rate of 25.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 140.42M | -25.06% |
| Dec 31, 2024 | 187.36M | 94.08% |
| Dec 29, 2023 | 96.54M | -2.09% |
| Dec 30, 2022 | 98.60M | 9.32% |
| Dec 31, 2021 | 90.19M | 88.56% |
| Feb 17, 2021 | 47.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Siemens Healthineers AG | 52.43B |
| Merck KGaA | 50.63B |
| Fresenius SE & Co. KGaA | 26.78B |
| Bayer Aktiengesellschaft | 26.78B |
| Fresenius Medical Care AG | 13.34B |
| Sartorius Aktiengesellschaft | 13.33B |
| Fielmann Group AG | 4.18B |
| Carl Zeiss Meditec AG | 3.93B |